Cannabis exposure during adolescence poses significant neurobiological risks during critical brain development periods. Understanding these risks, potential drug interactions, and contraindications is essential for parents, clinicians, and young users making informed decisions.
Cannabis impairs reaction time, visual processing, and motor coordination—critical functions for safe driving. Understanding how cannabinoids interact with medications and affect driving ability is essential for California consumers who use cannabis products.
Cannabis can significantly interact with common heart medications including beta-blockers, ACE inhibitors, and anticoagulants through CYP450 enzyme pathways, potentially affecting drug efficacy and cardiovascular stability. Understanding these interactions is essential for safe cannabinoid use in patients managing hypertension, arrhythmias, or thrombotic conditions.
Cannabis use during pregnancy and lactation poses significant risks to fetal development and infant health. Current evidence links prenatal cannabinoid exposure to altered brain development, reduced birth weight, and potential neurobehavioral effects in nursing infants.
THC interacts with serotonin regulation and dopamine pathways, creating documented risks for anxiety, psychosis, and mood destabilization—especially in vulnerable populations. Understanding contraindications and safe dosing practices is essential for harm reduction.
Cannabidiol (CBD) inhibits cytochrome P450 enzymes, potentially altering blood levels of dozens of common medications including blood thinners, antidepressants, and seizure drugs. Understanding these interactions is essential for safe, concurrent use.